Skip to main content
Browse topics  Search all clinical trials

Clinical trials : neurology

Showing 1 -7 of 7 results
A study to collect implanting physician feedback on the ability of the DRR to assist in identification and visualization of subject specific anatomy and in comparing the position of the ATI Neurostimulator within the subject specific anatomy during the implant procedure in the Pathway CH-2 trial.

Lenox Hill Hospital | 100 E 77th St | New York | NY 10075
Multi-center, interventional, randomized, placebo-controlled, parallel, triple-blind safety and efficacy study of sphenopalatine ganglion (SPG) stimulation in the treatment of chronic cluster headaches...

Lenox Hill Hospital | 100 E 77th St | New York | NY 10075
The purpose of this study is to compare the incidence of atrial fibrillation (AF) through 12 months between two groups. One group will have standard of care medical treatment, and the other group will have continuous cardiac rhythm monitoring via the Reveal LINQ Insertable Cardiac Monitor (ICM), also known as a "loop recorder"...

Multiple locations
Pilot study to investigate whether non-invasive brain stimulation with transcranial magnetic stimulation (TMS) can correct abnormal brain activity and improve symptoms in patients with dystonia.

Feinstein Institute for Medical Research | 350 Community Dr | Manhasset | NY 11030
The HEP2 study is designed to better understand the challenges of living with focal seizures that do not respond to medication, by following 205 people with medication-resistant focal epilepsy over two years to measure changes in health status, healthcare costs, quality of life, and biomarkers of epilepsy severity and treatment response...

Multiple locations
The purpose of the study is to use state-of-the-art imaging to identify areas of abnormal brain function in patients with dystonia in order to improve treatment of this movement disorder.

Feinstein Institute for Medical Research | 350 Community Dr | Manhasset | NY 11030
This study will be conducted to evaluate the safety and efficacy of sumatriptan nasal powder (AVP-825) compared to placebo in the acute treatment of migraine in adolescent participants, 12 through 17 years of age.

Neuroscience Institute at Great Neck | 611 Northern Blvd | Great Neck | NY 11021